Last updated on December 2019

Study to Assess Safety Tolerability Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies


Brief description of study

The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary antitumor activity of AZD4573 in subjects with relapsed or refractory haematological malignancies

Clinical Study Identifier: NCT03263637

Find a site near you

Start Over

Research Site

Heidelberg, Germany
9.15miles
  Connect »